Opportunity Information: Apply for PA 18 934
This funding opportunity, PA 18-934, is an NIH National Cancer Institute (NCI) administrative supplement program tied to existing Cancer Center Support Grants (P30). Its purpose is to strengthen the Geographic Management of Cancer Health Disparities Program (GMaP) by funding a small number of region-based hubs or networks anchored in NCI-designated Cancer Centers. The emphasis is on building and coordinating regional partnerships that expand cancer health disparities (CHD) research capacity, improve training and career development pathways for underrepresented investigators and trainees, and deepen outreach and access to cancer research and information in underserved communities. Clinical trials are not allowed under this supplement mechanism, keeping the focus on infrastructure, workforce development, and programmatic capacity rather than running intervention studies.
At the center of the FOA is the idea of regional linkage-building. NCI is looking for hubs that can connect Cancer Centers with institutions serving underserved health disparity populations and underrepresented students (ISUPS), along with other relevant organizations and agencies. In practical terms, that means developing a functioning network of local and regional contacts that can collaborate on CHD-related priorities, share resources, and create clearer pathways for students and early-stage investigators to enter and remain in cancer and CHD research careers. The program is designed to make those connections durable, not ad hoc, so that opportunities for mentorship, training, research exposure, and community-engaged work become more systematic across a region.
The GMaP program goals reflected in this FOA are threefold. First, it aims to support and enhance the science of cancer health disparities by strengthening the ecosystem that enables CHD research, such as shared infrastructure, cross-institutional collaboration, and evaluation of what improves CHD research productivity and relevance. Second, it aims to promote the development of the next generation of competitive cancer and CHD investigators, with a clear priority on individuals from underrepresented backgrounds. This includes recruitment, training, mentorship, professional development, and career advancement supports that can help trainees and early-career researchers progress toward independent, fundable research careers. Third, it aims to enhance access to cancer information and research among underserved communities, which aligns with outreach and engagement activities that can increase awareness, trust, and opportunities for community participation in the research continuum, short of conducting clinical trials.
Because these are administrative supplements to P30 Cancer Center Support Grants, the intent is to leverage what Cancer Centers already have: established research cores, training environments, community outreach structures, and administrative capacity. The FOA also explicitly points to leveraging NCI Center to Reduce Cancer Health Disparities (CRCHD) flagship programs, including CURE (Continuing Umbrella of Research Experiences), PACHE (Partnerships to Advance Cancer Health Equity), and the National Outreach Network (NON). In effect, applicants are expected to build on existing NCI investments and align their regional hub activities with these broader national initiatives, rather than creating isolated efforts.
Funding details in the source information indicate an expected total of seven awards, matching the concept of seven region-based hubs or networks. The listed award ceiling is $250,000, which signals a modest but targeted supplement intended to expand capacity, coordination, and evaluation rather than fund large-scale research projects. The opportunity sits within the Education and Health activity categories and is associated with CFDA 93.397. It was created on September 24, 2018, with an original closing date of December 17, 2018, indicating it was a time-limited competitive supplement announcement for Cancer Centers to extend their GMaP-related activities.
Eligibility is broad in the general listing and includes various levels of government, tribal entities, public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations, and small businesses, with a note to consult additional eligibility text for specifics. However, the operational reality of an administrative supplement to a P30 Cancer Center Support Grant is that the supplement typically flows through an existing eligible awardee institution holding the parent P30 grant, since the supplement is meant to add scope and resources to an already funded Cancer Center grant structure. The overall thrust is to use Cancer Centers as regional anchors to expand CHD research and workforce diversity efforts through partnerships, structured training and professional development, outreach, infrastructure development, and evaluation focused on reducing cancer inequities.Apply for PA 18 934
- The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program (Admin Suppl - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.397.
- This funding opportunity was created on Sep 24, 2018.
- Applicants must submit their applications by Dec 17, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 7 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH NCI Administrative Supplement PA 18-934 (GMaP Hubs/Networks)
What is PA 18-934?
PA 18-934 is a National Institutes of Health (NIH), National Cancer Institute (NCI) administrative supplement opportunity tied to existing Cancer Center Support Grants (P30). It supports a small number of region-based hubs or networks intended to strengthen the Geographic Management of Cancer Health Disparities Program (GMaP).
What is the main purpose of this supplement?
The purpose is to strengthen regional partnerships anchored in NCI-designated Cancer Centers in order to expand cancer health disparities (CHD) research capacity, improve training and career development pathways for underrepresented investigators and trainees, and deepen outreach and access to cancer research and information in underserved communities.
What is GMaP in the context of this funding opportunity?
GMaP refers to the Geographic Management of Cancer Health Disparities Program. In this FOA, it is operationalized through region-based hubs or networks that coordinate partners, resources, and career pathways to strengthen the regional ecosystem supporting CHD research and workforce development.
Who is expected to lead or anchor the regional hubs/networks?
The hubs or networks are expected to be anchored in NCI-designated Cancer Centers. Because this is an administrative supplement mechanism tied to P30 grants, the supplement typically flows through an institution holding the parent P30 Cancer Center Support Grant.
Is this a standalone grant, or does it require an existing grant?
It is an administrative supplement tied to existing Cancer Center Support Grants (P30). The structure and intent indicate it is meant to add resources and scope to an already funded Cancer Center grant infrastructure rather than operate as a standalone award.
How many awards are expected?
The information provided indicates an expected total of seven awards, aligning with the concept of seven region-based hubs or networks.
What is the maximum award amount?
The listed award ceiling is $250,000. This suggests funding is intended for targeted capacity-building, coordination, and evaluation activities rather than large-scale research projects.
What types of activities does this funding emphasize?
The emphasis is on building and coordinating regional partnerships, strengthening infrastructure and collaboration that enable CHD research, developing and supporting training and career pathways (especially for underrepresented individuals), and conducting outreach and engagement that improves access to cancer research and information in underserved communities.
Are clinical trials allowed under this supplement?
No. Clinical trials are not allowed under this supplement mechanism. The focus is on infrastructure, workforce development, programmatic capacity, and related coordination rather than running intervention studies.
What does "regional linkage-building" mean in practical terms here?
It means developing a functioning network of local and regional contacts that can collaborate on CHD priorities, share resources, coordinate mentorship and training opportunities, and create clearer pathways for students and early-stage investigators to enter and remain in cancer and CHD research careers across a region.
Which partner institutions are specifically highlighted?
The FOA highlights connecting Cancer Centers with institutions serving underserved health disparity populations and underrepresented students (ISUPS), as well as other relevant organizations and agencies that can support regional CHD research capacity, training, and outreach.
What are the three main program goals reflected in this FOA?
The goals are: (1) support and enhance the science of cancer health disparities by strengthening the ecosystem that enables CHD research (including shared infrastructure, cross-institutional collaboration, and evaluation); (2) promote development of the next generation of competitive cancer and CHD investigators, prioritizing individuals from underrepresented backgrounds; and (3) enhance access to cancer information and research among underserved communities through outreach and engagement activities (without conducting clinical trials).
How does the FOA address training and workforce diversity?
It prioritizes recruitment, training, mentorship, professional development, and career advancement supports aimed at helping trainees and early-career researchers, particularly those from underrepresented backgrounds, progress toward independent and fundable cancer and CHD research careers.
What kinds of outreach or community activities are in scope?
Activities that enhance access to cancer information and research among underserved communities are in scope, including outreach and engagement approaches that can increase awareness, trust, and opportunities for community participation across the research continuum, short of conducting clinical trials.
What is meant by making partnerships "durable, not ad hoc"?
The program aims for systematic, lasting regional connections rather than one-time collaborations. The intent is to make mentorship, training, research exposure, and community-engaged work more consistent and coordinated across institutions and communities within a region.
What existing resources are applicants expected to leverage?
Applicants are expected to leverage what Cancer Centers already have, such as established research cores, training environments, community outreach structures, and administrative capacity, and to build on existing NCI investments rather than creating isolated efforts.
Which NCI CRCHD flagship programs are explicitly referenced?
The FOA explicitly points to leveraging NCI Center to Reduce Cancer Health Disparities (CRCHD) flagship programs, including CURE (Continuing Umbrella of Research Experiences), PACHE (Partnerships to Advance Cancer Health Equity), and the National Outreach Network (NON).
How does evaluation fit into this opportunity?
Evaluation is included as part of strengthening the CHD research ecosystem, with an emphasis on assessing what improves CHD research productivity and relevance in the context of infrastructure, collaboration, and regional network building.
What are the activity categories and assistance listing information provided?
The opportunity is associated with the Education and Health activity categories and is linked to CFDA 93.397.
When was this opportunity created and when did it close?
It was created on September 24, 2018, and had an original closing date of December 17, 2018, indicating it was a time-limited competitive supplement announcement.
Who is eligible to apply based on the general listing?
The general eligibility listing includes various levels of government, tribal entities, public and private institutions of higher education, nonprofits (501(c)(3) and non-501(c)(3)), for-profit organizations, and small businesses, with a note to consult additional eligibility text for specifics.
How should organizations interpret eligibility given this is an administrative supplement?
While the general listing is broad, the operational reality described is that the supplement typically flows through an existing eligible awardee institution holding the parent P30 Cancer Center Support Grant, since the supplement is intended to add scope and resources to the existing Cancer Center grant structure.
What is the overall focus of the supplement compared to traditional research grants?
The overall thrust is capacity and coordination: expanding CHD research and workforce diversity efforts through partnerships, structured training and professional development, outreach, infrastructure development, and evaluation focused on reducing cancer inequities, rather than funding large intervention studies or clinical trials.
Browse more opportunities from the same category: Education, Health
Next opportunity: Energy and Mineral Development Program
Previous opportunity: Head Start and/or Early Head Start Grantee - The Cities of Kingsland and Rison, and the community of Woodlawn within Cleveland County, Arkansas
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 934
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 934) also looked into and applied for these:
| Funding Opportunity |
|---|
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Optional) Apply for RFA DA 19 008 Funding Number: RFA DA 19 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) Apply for PAR 19 032 Funding Number: PAR 19 032 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed) Apply for PA 19 035 Funding Number: PA 19 035 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) Apply for RFA CA 19 013 Funding Number: RFA CA 19 013 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $900,000 |
| HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional) Apply for RFA DA 19 024 Funding Number: RFA DA 19 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed) Apply for RFA DA 19 023 Funding Number: RFA DA 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) Apply for RFA CA 19 029 Funding Number: RFA CA 19 029 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Apply for RFA CA 19 030 Funding Number: RFA CA 19 030 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 022 Funding Number: RFA CA 19 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 021 Funding Number: RFA CA 19 021 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 020 Funding Number: RFA CA 19 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 019 Funding Number: RFA CA 19 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 19 027 Funding Number: RFA CA 19 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 19 025 Funding Number: RFA CA 19 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 19 026 Funding Number: RFA CA 19 026 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 19 023 Funding Number: RFA CA 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 19 024 Funding Number: RFA CA 19 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Distance Learning and Telemedicine Grants. Apply for RUS 19 02 DLT Funding Number: RUS 19 02 DLT Agency: Department of Agriculture, Utilities Programs Category: Education, Health Funding Amount: $500,000 |
| Distance Learning and Telemedicine Grants--Opioid. Apply for RUS 19 01 DLT Funding Number: RUS 19 01 DLT Agency: Department of Agriculture, Utilities Programs Category: Education, Health Funding Amount: $500,000 |
| Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) Apply for RFA CA 19 034 Funding Number: RFA CA 19 034 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 934", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.